Vivos Therapeutics Shares Surge After $4.5 Million Debt Conversion Fuels Nasdaq Optimism
Vivos Therapeutics shares surged Friday after the sleep apnea device company said its main lender will exchange as much as $4.5 million in debt for equity. The company said the deal is aimed at reducing balance sheet stress and helping it stay on the Nasdaq.
Company hubNASDAQ:VVOS
Vivos Therapeutics (VVOS) Stock News & Analysis
Follow the latest Vivos Therapeutics (VVOS) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
TechStock² Updates
